LANSING, Mich., April 3, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company"), the leading developer of advanced spider silk based fibers, will hold a shareholder meeting on April 16, 2013. Along with the notice of meeting, the Company's founder and CEO, Kim K Thompson has posted a letter to the shareholders on the Company's website.
"We plan to continue accelerating our commercial development through 2013 and beyond," said CEO and founder Kim K Thompson. "We will also be announcing a shareholder conference call to be held sometime after the shareholders' meeting, to discuss our progress and ambitious plans for 2013 and 2014."
To view the letter to shareholders as well as the notice of the shareholder meeting along with details regarding the meeting please go to www.KraigLabs.com. The letter to shareholders and the notice of the shareholder meeting are also being provided to shareholders through electronic communication, for those who have previously opted for electronic communication or through the US postal service.
Furthermore, the Company is inviting shareholders to join the Kraig e-mail alert list, which will allow the Company to communicate more effectively with its shareholder community. For periodic updates, notices and important press releases, please subscribe by sending an email containing the words "shareholder, add me to the list" to Shareholder@KraigLabs.com
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc